Treatment of AML cells with CPT1a inhibitor significantly increased free FAs and glucose uptake specifically in the co-cultures with bone marrow adipocytes; underlining the vital role of the microenvironment in regulating energy demands and chemotherapy response (158). This evidence concerns the gene CPT1A and acute myeloid leukemia.